Is venetoclax appropriate for relapsed CLL patients?
Panel discussion on new technologies in lymphoma - the applications of circulating tumor DNA
Ash Alizadeh et al.
Clinical trials, pathologies and developments in personalized medicine
Francesco d'Amore et al.
New initiatives in the treatment of myeloma
ADCT-402 - a drug to watch